FrançaisMovember

Prostate Cancer

Movember
For more information visit
www.movember.com

In The News

PSA Fitness (Power, Strength & Agility)
HALIFAX, N.S., January 16, 2012/CNW/ Prostate Cancer Canada Atlantic is proud to announce the launch of PSA Fitness (Power, Strength & Agility), a free nine week exercise program for men who have been diagnosed with prostate cancer.  PSA Fitness, resistance training and yoga, is an important patient-centered therapy for prostate cancer survivors in Halifax.

TELUS donation to support Prostate Cancer Canada
Toronto, ON- January 13, 2012- On January 10th, Prostate Cancer Canada received a generous donation of $100,000 from TELUS at the launch of the TIEd Together exhibition. TELUS’ donation was made possible through the Canadian Football League Grey Cup cause marketing campaign. The donation will support Prostate Cancer Canada’s ongoing efforts to eliminate the disease through research, education, support and awareness.

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.


Prostate Cancer Assessment Tools

To help men understand their diagnosis and prognosis and make treatment decisions, we have created a set of online tools called the Prostate Cancer Assessment Tools. If your doctor has recommended a prostate biopsy or you have prostate cancer, use the tools to answer a variety of questions, such as:
  • What are the odds a biopsy will find cancer?
  • What are the chances my cancer has spread outside the prostate?
  • What are the odds my cancer will relapse after surgery?
  • What are the odds I will die of prostate cancer?
You will need information from your doctor, such as biopsy results, test results, Gleason scores, etc. All results should be brought back to your doctor for further informed discussion regarding treatment options. The information you find is not a substitute for your doctor’s diagnosis or prognosis. It is meant to help you and your doctors make clinical decisions.

These tools created by a team of researchers led by Dr. Pierre Karakiewicz, MD, urologist and director of the Cancer Prognostics and Health Outcomes Unit at the University of Montreal Health Centre. They are based on nomograms - statistic tools based on thousands of real-life prostate cancer cases – that were published in the Journal of Urology. These tools are, on average, 80 per cent accurate and provide calculated predictions of outcomes and are free of bias and subjectivity.

Use the Prostate Cancer Assessment Tools. Assessment Disclaimer.

Information published on the Prostate Cancer Canada website is provided for informational and educational purposes only. Information provided on this website, including information derived from the Prostate Cancer Assessment Tools (PCATs) and the prostate cancer nomograms, is not designed or intended to constitute medical advice or to be used for diagnosis. The PCATs are intended to provide information on your condition and to help inform your consultations with medical professionals. The information obtained from this website should not be a substitute for medical advice from a qualified medical professional.

Prostate Cancer Canada and the Centre Hospitalier de l'Université de Montréal assume no responsibility or liability for any consequence resulting directly or indirectly for any action or inaction you take based on or made in reliance on the information, services, or material on or linked to this site.

 

 

 
Did you know? Rates of prostate cancer in men are comparable to rates of breast cancer in women. #1in7men.
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital